Research and experimental development on natural sciences and engineering
ENZYFERM HOLDING AS
Operating profit
NOK −68
Equity
NOK 1.3m
Incorporated
2024
Share capital
NOK 54,000
Roles
Regnskapsfører
Styrets lederNils Kristian Liveng-Ness
StyremedlemÅsa Karolina Bengtsson
StyremedlemOle Roterud
StyremedlemLeif Christian Hanstad
StyremedlemGilbert Kofi Adarkwah
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| FBV HOLDING AS | 29.4% | 158178.000000 | 2025 |
| GRISELDA AS | 29.4% | 158178.000000 | 2025 |
| SIAVASH SEIFOLLAHY FAKHR | 27.5% | 148067.000000 | 2025 |
| GILBERT AND PARTNERS AS | 4.1% | 21923.000000 | 2025 |
| NORLOM AS | 3.9% | 20962.000000 | 2025 |
| AVANZUS AS | 1.9% | 10000.000000 | 2025 |
| AFR INVEST AS | 1.9% | 10000.000000 | 2025 |
| WILLIAM HOUSTON OLDHAM | 1.0% | 5385.000000 | 2025 |
| NYBAKK INVEST AS | 0.7% | 3846.000000 | 2025 |
| MURPHDOG HOLDING AS | 0.4% | 1923.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ENZYFERM AS | Active | 100.0% | 300000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.